67th Annual Scientific Meeting Pre-Course 1: Advancing the Safety of LGBTQIA+ Patients in Headache Clinical Care

Course Instructions

  1. AHS members have complimentary access to the recorded content within this course. All others should create a new visitor account or login as a visitor to purchase the course.
  2. Once logged in or purchased, click "Take course" to access recorded content, complete the meeting evaluation, claim CME, and download a certificate.

Target Audience

The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

Learning Objectives

At the conclusion of the program, participants will report their intention to:

  1. Identify how felt and enacted stigma negatively impact the diagnosis, management, and disease course of LGBTQIA+ patients with headache disorders; and learn how to mitigate these risks and enhance patient safety in clinical practice
  2. Understand how to assess for factors that may impact patient safety outside the clinic, such as intimate partner violence, recreational drug use, housing and food insecurity, among others; and learn how to support and provide resources for headache patients who are experiencing physical and sexual abuse, trauma and violence
  3. Learn about potential drug-drug interactions that are unique to these populations, including how headache medications may interact with GAHT, PrEP and DoxyPEP, and certain recreational and/or psychoactive substances
  4. Review how childhood trauma, puberty, and the socio-cultural-political environment impact care for LGBTQIA+ pediatric populations in headache
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation
Course opens: 
07/01/2025
Course expires: 
08/01/2026
Cost:
$500.00

Disclosure Information

The planners and faculty for this activity did not have any relationships to disclose unless listed below. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

PURPOSE/OBJECTIVE

This educational activity is designed to enhance the clinical competence and confidence of healthcare providers in delivering inclusive, evidence-based care for LGBTQIA+ patients with headache disorders. Participants will explore how felt and enacted stigma contribute to disparities in diagnosis, management, and outcomes, and will gain practical strategies to mitigate these risks and improve patient safety. The activity will also address social determinants of health—such as intimate partner violence, substance use, and housing or food insecurity—and equip learners with tools to support patients experiencing trauma and abuse. Attendees will deepen their understanding of clinically relevant drug-drug interactions involving gender-affirming hormone therapy (GAHT), HIV prevention medications (PrEP and DoxyPEP), and recreational substances. Finally, learners will review the unique challenges in caring for LGBTQIA+ youth, including the effects of childhood trauma, puberty, and sociocultural stressors, with a focus on providing affirming and developmentally appropriate care in headache medicine.

ACCREDITATION STATEMENT

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society® designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS FOR CLAIMING CME:

  • Login/create a new visitor account (when creating an account, please be sure to use the email address you used during registration for the Annual Meeting).
  • Watch the session recording.
  • Complete the post-activity evaluation. 
  • Enter the number of CME credits being claimed*.
  • Download your certificate.

*Please note: The maximum number of credits is calculated based on watching the entire session recording.

FINANCIAL DISCLOSURES

The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERCIAL SUPPORT

The American Headache Society® received support for the ASM2025 meeting from the following organizations:

AbbVie
Lundbeck LLC
Pfizer Inc.

BIBLIOGRAPHY

References are available within the session recording.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Participation

Price

Cost:
$500.00
Please login or register to take this course.